New skin cancer therapy shrinks tumors

A new drug for melanoma has been shown to rapidly shrink malignant tumors in an early trial at Memorial Sloan-Kettering Hospital in New York. Among 27 patients whom the experimental new drug was tested on, “19 showed a 30 percent or greater reduction in tumor size,” Dr